Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Goodwill & Intangibles (2019 - 2025)

Silence Therapeutics' Goodwill & Intangibles history spans 7 years, with the latest figure at $10.9 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles rose 12.42% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $10.9 million, up 12.42%, while the annual FY2025 figure was $10.9 million, 12.42% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $10.9 million at Silence Therapeutics, roughly flat from $10.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $10.9 million in Q2 2025 and bottomed at $9.4 million in Q3 2024.
  • The 5-year median for Goodwill & Intangibles is $10.1 million (2025), against an average of $10.2 million.
  • The largest annual shift saw Goodwill & Intangibles fell 5.55% in 2021 before it increased 16.18% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $10.3 million in 2021, then dropped by 4.84% to $9.8 million in 2022, then increased by 3.21% to $10.1 million in 2023, then fell by 3.76% to $9.7 million in 2024, then grew by 12.42% to $10.9 million in 2025.
  • Per Business Quant, the three most recent readings for SLN's Goodwill & Intangibles are $10.9 million (Q4 2025), $10.9 million (Q3 2025), and $10.9 million (Q2 2025).